Clinical Outcomes of Pediatric Chronic Intestinal Pseudo-Obstruction
- PMID: 34071279
- PMCID: PMC8198288
- DOI: 10.3390/jcm10112376
Clinical Outcomes of Pediatric Chronic Intestinal Pseudo-Obstruction
Abstract
Chronic intestinal pseudo-obstruction (CIPO) is an extremely rare condition with symptoms of recurrent intestinal obstruction without any lesions. The outcomes of pediatric CIPO and predictors for the outcomes have not yet been well established. We analyzed the clinical outcomes and associated factors for the outcomes of pediatric CIPO. We retrospectively reviewed 66 primary CIPO patients diagnosed between January 1985 and December 2017. We evaluated parenteral nutrition (PN) factors such as PN duration, PN use over 6 months, home PN, and mortality as outcomes. We selected onset age, presence of urologic symptoms, pathologic type, and involvement extent as predictors. The early-onset CIPO was found in 63.6%, and 21.2% of the patients presenting with urologic symptoms. Of the 66 patients, 47 and 11 had neuropathy and myopathy, respectively. The generalized involvement type accounted for 83.3% of the cases. At the last follow-up, 24.2% of the patients required home PN management. The mean duration of PN was 11.8 ± 21.0 months. The overall mortality rate of primary CIPO was 18.2%. PN factors were predicted by the urologic symptoms and extent of involvement. However, mortality was predicted by pathologic type. The onset age was not significantly associated with the outcomes. CIPO with urologic symptoms and generalized CIPO had poor PN outcomes. Myopathy is suggested as a predictor of mortality in children with primary CIPO.
Keywords: chronic intestinal pseudo-obstruction; myopathy; neuropathy; parenteral nutrition; pediatrics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The chronic intestinal pseudo-obstruction subtype has prognostic significance in patients with severe gastrointestinal dysmotility related intestinal failure.Clin Nutr. 2018 Dec;37(6 Pt A):1967-1975. doi: 10.1016/j.clnu.2018.09.008. Epub 2018 Sep 22. Clin Nutr. 2018. PMID: 30290972
-
ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis.J Neurogastroenterol Motil. 2022 Jan 30;28(1):104-110. doi: 10.5056/jnm20243. J Neurogastroenterol Motil. 2022. PMID: 34980693 Free PMC article.
-
Latest developments in chronic intestinal pseudo-obstruction.World J Clin Cases. 2020 Dec 6;8(23):5852-5865. doi: 10.12998/wjcc.v8.i23.5852. World J Clin Cases. 2020. PMID: 33344584 Free PMC article. Review.
-
Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition.Am J Gastroenterol. 2009 May;104(5):1262-70. doi: 10.1038/ajg.2009.58. Epub 2009 Apr 14. Am J Gastroenterol. 2009. PMID: 19367271
-
[Chronic intestinal pseudo-obstruction].Gastroenterol Clin Biol. 2006 Aug-Sep;30(8-9):975-85. doi: 10.1016/s0399-8320(06)73359-0. Gastroenterol Clin Biol. 2006. PMID: 17075444 Review. French.
Cited by
-
Special Issue "Clinical Advances in Chronic Intestinal Diseases Treatment".J Clin Med. 2022 Feb 25;11(5):1258. doi: 10.3390/jcm11051258. J Clin Med. 2022. PMID: 35268348 Free PMC article.
-
Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 Meeting.Dig Dis Sci. 2023 Oct;68(10):3857-3871. doi: 10.1007/s10620-023-08066-1. Epub 2023 Aug 31. Dig Dis Sci. 2023. PMID: 37650948 Free PMC article. Review.
-
Changes in the intestinal expression of drug metabolism-related genes in a piglet model of parenteral nutrition.Nutr Metab (Lond). 2022 Mar 9;19(1):18. doi: 10.1186/s12986-022-00654-8. Nutr Metab (Lond). 2022. PMID: 35264190 Free PMC article.
-
Incidence, diagnostics, therapeutic management and outcomes of paediatric intestinal pseudo-obstruction in the Netherlands: A 20-year retrospective cohort study.J Pediatr Gastroenterol Nutr. 2025 Jan;80(1):34-45. doi: 10.1002/jpn3.12400. Epub 2024 Nov 1. J Pediatr Gastroenterol Nutr. 2025. PMID: 39487095 Free PMC article.
-
Persistent abdominal distension, bilious emesis, and feeding intolerance in an infant without anatomical bowel obstruction.JPGN Rep. 2024 Dec 18;6(1):65-68. doi: 10.1002/jpr3.12151. eCollection 2025 Feb. JPGN Rep. 2024. PMID: 39944097 Free PMC article. No abstract available.
References
-
- Muto M., Matsufuji H., Tomomasa T., Nakajima A., Kawahara H., Ida S., Ushijima K., Kubota A., Mushiake S., Taguchi T. Pediatric chronic intestinal pseudo-obstruction is a rare, serious, and intractable disease: A report of a nationwide survey in Japan. J. Pediatr. Surg. 2014;49:1799–1803. doi: 10.1016/j.jpedsurg.2014.09.025. - DOI - PubMed
-
- Stanghellini V., Cogliandro R.F., De Giorgio R., Barbara G., Cremon C., Antonucci A., Fronzoni L., Cogliandro L., Naponelli V., Serra M. Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant. Proc. 2010;42:15–18. doi: 10.1016/j.transproceed.2009.12.017. - DOI - PubMed
-
- Thapar N., Saliakellis E., Benninga M.A., Borrelli O., Curry J., Faure C., De Giorgio R., Gupte G., Knowles C.H., Staiano A. Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group. J. Pediatr. Gastroenterol. Nutr. 2018;66:991–1019. doi: 10.1097/MPG.0000000000001982. - DOI - PubMed
LinkOut - more resources
Full Text Sources